Real-World Effectiveness of Belimumab in the Treatment of Systemic Lupus Erythematosus: Pooled Analysis of Multi-Country Data from the OBSErve Studies
ConclusionsBelimumab improves clinical manifestations of SLE and is associated with GCS dose reductions in a real-world clinical setting, supporting the real-world effectiveness of belimumab for SLE.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research
More News: Argentina Health | Canada Health | Germany Health | Lupus | Prednisone | Rheumatology | Spain Health | Study | Switzerland Health